Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

SelectImmune Pharma reports significant patent progress across the project portfolio

Selectimmune Pharma is pleased to announce a continued strengthening of its intellectual property portfolio through a number of recent patent grants.Following extensive research into the treatment of cystitis using interleukin-1 receptor antagonists (IL1-RA), patent protection was sought in Europe, the US and Australia. The US and Australian patent offices granted protection in May of this year and the European Patent Office recently announced acceptance of the patent claims. Grant of the European patent is therefore expected to follow soon.  Selectimmune Pharma continues to seek

SelectImmune Pharma will implement reporting in English

SelectImmune Pharma is extending its presence on the international Pharmaceutical arena, where research & development as well as clinical study results and strategic partnerships are typically reported in English. Hence the company Board of Directors has decided to change the company reporting language to English from 2021/2022 and onwards. The web site will feature parallel documents in English and Swedish, including Annual and quarterly reports and press releases.   For more information, please contact: Catharina Svanborg Chairman of the board SelectImmune Pharma AB

poLight ASA - Invitation to presentation of Q2 2021 results

poLight ASA will release its Q2 2021 results on Friday 20 August 2021 at 7.00 am CEST. The quarterly report and presentation will be made available on the company's website www.polight.com and www.newsweb.no. CEO Øyvind Isaksen and CFO Alf Henning Bekkevik will present the company's results at 08:30 am CEST through live webcast.Please join the Q2 2021 results webcast by clicking here: https://channel.royalcast.com/landingpage/hegnarmedia/20210820_4/ 

Enersense International Plc Half-year report 2021: Positive result and market

Enersense International Plc  Stock Exchange Release 13 August 2021 at 12 p.m. This release is a summary of Enersense International Plc’s January-June 2021 Half-year Financial Report. The complete report is attached to this release as a pdf file. It is also available on the company's website at www.enersense.com/investors.April–June 2021   · Turnover EUR 61.6 million (16.4), +275.2% year-on-year   · EBITDA EUR 5.8 million (1.1), EBITDA margin 9.4% (6.4)  · Operating profit EUR 3.0 million (0.7), profit margin 4.9% (4.4)  · Order backlog EUR 301 million at the end of the

Scandinavian ChemoTech participates in the European Oncology Convention 2021

Mohan Frick will participate and present at the European Oncology Convention 2021 that is held in Birmingham, UK on 15-16 September.The Oncology Convention is dedicated to advancing clinical oncology and life-saving research. The show provides the perfect platform to source the latest innovations and CPD accredited education in preventing, diagnosing, treating, and caring for breast, colorectal, lung and prostate cancer. A CPD accredited seminar programme will run alongside the exhibition, hosted by the leading clinicians and researchers in worldwide cancer prevention, diagnosis,

Norway Royal Salmon (NRS): Invitation to Webcast of Q2 2021 on 23 August 2021 at 8:00 am (CET)

A presentation in Norwegian of NRS's interim report Q2 2021 will be held at 8:00 am (CET) on 23 August 2021. The presentation will be transmitted live in Norwegian on NRS's website www.norwayroyalsalmon.com. Participants will have the opportunity to submit questions online throughout the webcast and a Q&A session will be held at the end of the presentation. A recording of the webcast in Norwegian will be made available on our website www.norwayroyalsalmon.com immediately after the presentation and an English version will be available at 10:00 (CET) the same day. The company's CEO

CS MEDICA A/S approved for listing at Spotlight Stock Market, publishes prospectus

CS MEDICA A/S (”CS MEDICA” or the ”Company”) hereby announces that the Company has been approved for listing at Spotlight Stock Market. The approval is given under the condition that CS MEDICA, a Danish medico cannabis company, raises the minimum limit in the Company's forthcoming issue of units and that the Company obtains a sufficient number of shareholders, in accordance with Spotlight Stock Market’s regulations. Further, CS MEDICA today publishes the prospectus for the upcoming issue of units (shares and free of charge warrants), which amounts to a total of approx. DKK 33.1 million. The

Members of the board of directors and the management team of Pharmacolog exercise all held warrants of series TO1 for approximately SEK 1.47 million

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE.Board members and management in Pharmacolog i Uppsala AB (publ) (”Pharmacolog” or the “Company”) have exercised all of their warrants of series TO1. The subscription period for TO1

Publishing of Apetit Plc’s Half-Year Report for January-June 2021 on 20 August 2021

Apetit Plc, Press release 13 August 2021 at 11:00 a.m.Apetit Plc will publish its Half-Year Report for January-June 2021 on Friday, 20 August 2021 at 8:30 a.m. The release can be found on the company’s website at apetit.fi after its publishing. A news conference (in Finnish) will be held as a live webcast on 20 August 2021 at 10:00. The news conference can be followed at apetit.fi/for-investors. The presentation material and a recording of the webcast will be available on the company’s website after the news conference. Apetit Plc For more information, please contact: Sanna

Metso Outotec complements the crusher head portfolio with the robust solution for large Nordberg crushers

Metso Outotec Corporation’s press release on August 13, 2021, at 11:00 a.m. EESTMetso Outotec introduces a new crusher head to complete the portfolio for Nordberg® MP800, MP1000, MP1250, HP800, and HP900 crushers. The Xtreme (forged) head is the most robust head on the market designed to handle the most demanding applications. “Metso Outotec now has a complete range of crusher heads in the portfolio and our customers can choose the level of durability based on their application and needs. The new Xtreme forged head is the most reliable crusher head in the industry. The OEM design ensures

Finnfund’s investment in digital connectivity dramatically increases access to internet in East, Central and South Africa

Finnfund provides a 12 million US dollar senior loan to Bandwidth and Cloud Services Group  (BCS), a telecom infrastructure provider operating in several African countries. With Finnfund’s help as a key project investor, BCS is expanding its operations in East, Central and South Africa. The project increases reliability, accessibility and affordability of the internet when compared to the alternatives.  “Large areas still rely on satellite connections, and in many of these countries, data transfer prices are amongst the highest in the world”, says Yonas Maru,

Veriff Expands Services to 39 Languages

Veriff adds four new languages to meet growing global customer demandVeriff, a global identity verification provider, today announced the addition of four new languages to its identity verification platform for a total of 39 languages and dialects. The new languages include Indonesian, Greek, Danish and Catalan. Veriff initially launched its service in English and soon added Estonian, Polish, Russian, Spanish, Brazilian Portuguese, German, and Latvian. Now, Veriff’s verification process is available in Arabic, Bulgarian, Catalan, Chinese (simplified), Croatian, Czech, Danish, Dutch,

Correction: Norway Royal Salmon ASA (NRS): Mandatory notification of trade

The english version of the press release published on 12 aug 2021 22:18 cest wrongly contained an average price of  209.9055 per share for the 61,480 shares NTS ASA ("NTS")  purchased through the market on 12 August 2021 in Norway Royal Salmon ASA ("NRS"). The correct price is shown in the message below and in the attachment.                                                                                                                                                                                                                         * * * NTS ASA ("NTS") has on 12 August 2021

Shahriare Mahmood joins Spinnova's Management Team

Sustainable textile material company Spinnova has appointed Shahriare Mahmood as Chief Sustainability Officer and member of the management team.As Chief Sustainability Officer, Shahriare Mahmood will be responsible for Spinnova’s sustainability and textile development, reporting to the Chief Executive Officer. Both textile development and ensuring sustainable supply chains are Mahmood’s area of expertise. As part of its strategy, Spinnova is developing both fibre and its own fabric made of the SPINNOVA® fibre, as well as applications with brand partners. The first commercial factory

Sleep Cycle interim report January-June 2021:  Continued growth coupled with increased investments in marketing, headcount and stock exchange listing

During the second quarter the number of subscribers continued to grow to a total of 852k, an increase of 14.5%. Net revenues increased by 12.5%, corresponding to 20.3% adjusted currency. Growth was driven by high renewal rates, effective investment in marketing and new growth initiatives such as B2B sales and partnership programs. Increased spend on marketing, a growing organization and the stock exchange listing contributed to a planned increase in costs and therefore a decline in net income for this quarter.Second quarter summary (April-June 2021) · Net sales increased by 12.5 (37.1)

Implantica appoints new experienced team to lead commercial operations

Implantica AG (publ) today announces that a new team will be heading up the commercial operations at the Company including four highly experienced sales and marketing professionals, two of whom are joining in August 2021. Stefan Vogt is joining as Chief Commercial Officer, having extensive experience in building large sales organisations. Steffen Schanz is joining as VP Marketing and Product Management, with his substantial implant marketing experience. Gerhard Landwehr has been appointed VP Business Development DACH and UK, with over 10 years’ experience in leading positions commercialising

Sedana Medical receives approval in France

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the company has received market approval for inhaled sedation in France.The approval applies to the drug Sedaconda (isoflurane)* for administration via the medical device AnaConDa (undergoing name change to Sedaconda ACD) for inhaled sedation in intensive care in France. The application has been approved by the French Medicines Agency, L'Agence nationale de sécurité du médicament et des produits de santé (ANSM) and is based on the DCP approval Sedana Medical received in July. “The approval has gone faster than we

Notice of Annual General Meeting in Sectra AB (publ)

The shareholders of the medical imaging IT and cyber security company Sectra AB (publ) are hereby invited to the Annual General Meeting held on Tuesday, September 14, 2021.Extraordinary measures due to the covid-19 pandemicSectra is keen to safeguard the wellbeing of the shareholders and seeks to contribute to the efforts to reduce the spread of the corona virus. The Board of Directors of Sectra has therefore decided that the Annual General Meeting (“AGM”) shall be conducted without the physical presence of shareholders, proxy holders and guests and that the shareholders shall be able to

Bio-Works confirms two new orders from contract manufacturer Catalent Biologics

Bio-Works Technologies AB has confirmed that they have received two new orders from contract manufacturer Catalent Biologics for a total order value of 778 KSEK (94,512 USD). The orders are expected to ship in the second half of this year. “We are proud that Catalent Biologics has chosen Bio-Works to supply chromatography resins for this project. Catalent Biologics is a fast-growing, global contract manufacturer with innovative technologies and integrated solutions that are leveraged by companies ranging from small biotech to large biopharma. Their deep expertise and patient first

Invitation to LeadDesk’s January–June 2021 results briefing

LeadDesk Plc Press Release 13 August 2021 8.05 CETLeadDesk will publish their 1.1.-30.6.2021 financial statements bulletin on Friday, 27 August 2021 at 8.00 CET (at 9.00 Finnish time). The company is organising a results briefing for analysts, the media and investors on 27 February 2021 at 9.00 CET (at 10.00 Finnish time). The briefing will be held as a Microsoft Teams webcast.LeadDesk CEO Olli Nokso-Koivisto will host the briefing and present the financial statement as well as forecasts for the second half of the year 2021. The event will be held in English. LeadDesk kindly asks

MPC Container Ships ASA announces date for Q2 and six-month 2021 results

Oslo, 13 August 2021 - MPC Container Ships ASA (the "Company") will be releasing its second quarter 2021 report prior to market opening on Thursday 19 August 2021. The Company will host a webcast for the presentation of the Q2 2021 results commencing on Thursday 19 August 2021 at 15:00 hours CEST / 09:00 hours EDT. The presentation will be made available on the Company’s webpage from 12:00 hours CEST / 06:00 hours EDT. There will be a Q&A session after the presentation. The event is being streamed. It is recommended that you listen

First Camp Group Interim report Q2 2021

First Camp, Scandinavia’s largest campsite chain, increased revenues in the second quarter of 2021 by 23% vs same period in 2020, excluding effects from acquisitions (pro forma).Highlights for second quarter 2021 (same quarter last year in brackets) · Total revenue of SEK 101.8 million (81.7) · Pro forma revenue increased with 23% compared to Q2 2020 · EBITDA of SEK 12.4 million (7.4) · Pro forma Adjusted EBITDA amounted to SEK 8.5 million (6.1) · Cash flow from operating activities of SEK 63.7 million (45.3) Highlights for the first two quarters 2021 (same period last

TR-1: notification of major holdings

TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN BMG4209G2077 Issuer Name GULF KEYSTONE PETROLEUM LIMITED UK or Non-UK Issuer Non-UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name BlackRock, Inc. City of registered office (if applicable) Wilmington Country of registered office (if applicable) USA 4. Details of the shareholder Full name of shareholder(s) if different from the person(s) subject to the notification

Kamux saw very strong growth, revenue +52.0% - Adjusted operating profit (EBIT) at previous year’s level

Kamux Corporation                Half Year Financial Report                           August 13, 2021 at 09:00 Kamux Corporation’s Half Year Financial Report for January 1 - June 30, 2021 Kamux saw very strong growth, revenue +52.0% - Adjusted operating profit (EBIT) at previous year’s level The figures in parentheses refer to the comparison period, i.e. the same period in the previous year, unless stated otherwise. April-June in brief · Revenue increased by 52.0%, totaling EUR 228.8 million (150.5) · Gross profit decreased by -0.5% to EUR 20.5 million (20.6), or 9.0% (

There are no items matching the current filter
There are no more items matching the current filter
Back to top